Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases.
Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases.
复制标题
DOI:
10.2337/dc12-1577
复制
发表时间:
2013-07
期刊:
影响因子:
16.2
通讯作者:
Samet JM
中科院分区:
文献类型:
--
作者:
Park C;Guallar E;Linton JA;Lee DC;Jang Y;Son DK;Han EJ;Baek SJ;Yun YD;Jee SH;Samet JM
Although diabetes increases the risk of cardiovascular disease (CVD) and mortality, the dose-response relationship between fasting glucose levels below those diagnostic of diabetes with cardiovascular events has not been well characterized. A prospective cohort study of more than one million Koreans was conducted with a mean follow-up of 16 years. A total of 1,197,384 Korean adults with no specific medical conditions diagnosed were classified by baseline fasting serum glucose level. Associations of fasting glucose level with CVD incidence and mortality, stroke incidence and mortality, and all-cause mortality were analyzed using multivariate proportional hazards regression. The relationships between fasting glucose levels and CVD risks generally followed J-shape curves, with lowest risk in the glucose range of 85–99 mg/dL. As fasting glucose levels increased to >100 mg/dL, risks for CVD, ischemic heart disease, myocardial infarction, and thrombotic stroke progressively increased, but risk for hemorrhagic stroke did not. Fasting glucose levels <70 mg/dL were associated with increased risk of all stroke (hazard ratio 1.06, 95% CI 1.01–1.11) in men and (hazard ratio 1.11, 1.05–1.17) in women. Both low glucose level and impaired fasting glucose should be considered as predictors of risk for stroke and coronary heart disease. The fasting glucose level associated with the lowest cardiovascular risk may be in a narrow range.
登录
查看更多内容
影响因子:
16.2
作者:
Pankow, James S.;Kwan, David K.;Ballantyne, Christie M.
通讯作者:
Ballantyne, Christie M.
影响因子:
8.3
作者:
Tanne, D;Koren-Morag, N;Goldbourt, U
通讯作者:
Goldbourt, U
DOI:
10.1056/nejmoa0908359
发表时间:
2010-03-04
期刊:
The New England journal of medicine
影响因子:
--
作者:
Selvin E;Steffes MW;Zhu H;Matsushita K;Wagenknecht L;Pankow J;Coresh J;Brancati FL
通讯作者:
Brancati FL
影响因子:
16.2
作者:
Balkau, B;Bertrais, S;Eschwege, E
通讯作者:
Eschwege, E
影响因子:
2.9
作者:
Kimm H;Yun JE;Lee SH;Jang Y;Jee SH
通讯作者:
Jee SH